Do you live in the Appalachian region and are you currently pregnant? Then I'd like to hear about your experience! Compensation provided.

Do you exercise regularly? Are you between 18-35 years old? If so, you may be eligible to participate in a research study examining how the brain, eyes, and heart work together to maintain balance. Compensation provided.

Are you a nurse in Saudi Arabia? We want to hear from you! Join our UNC study to share your thoughts on using genetics in nursing. Your feedback will help shape better nursing education and support your daily work.

This research study (IRB # 24-3153) involves completing an attention task on the computer with an EEG cap on your head. The attention task itself will take 50 minutes. The whole study (questionnaires, EEG setup, and study conclusion) will take two hours. This study aims to explore aspects of attention and to understand what happens in the brain when attention stays on something. Participants who have completed the study will earn $20 for their participation.

Do you suffer from migraines? Are you interested in helping with migraine research?

Do you have a blood cancer or have received a stem cell transplant and have been diagnosed with a respiratory infection? If so, you might be eligible to take part in a study to see if an experimental treatment is effective at reducing the severity of the respiratory infection.

Do you have Acute Myeloid Leukemia (AML) and want to try a new study drug that might help treat your cancer?

We are enrolling participants in a research study focused on a new treatments for food allergy. If you or your child have a diagnosed egg, milk or peanut allegry, you may be eligible to take part. This is a unique opportunity to help advance care and contribute to future therapies. Participation is voluntary, and all study-related care is provided at no cost. Contact us to learn more.

Have you been diagnosed with GCB Subtype of Diffuse LargeB-cell Lymphoma (DLBCL)? If so, you may be able to take part in a research study looking at Evaluating the Efficacy and Safety of Zilovertamab Vedotin (MK-2140) Plus R-CHP Versus Polatuzumab Vedotin Plus R-CHP in Treatment-naïve Participants With GCB Subtype of Diffuse Large B-cell Lymphoma (DLBCL

Do you feel that your reaction time has slowed after your ACL injury? Has your ability to make decisions on the field/gym/court been impacted? If so, you may be eligible for a study examining the effect a quick joint manipulation has on your reaction time and decision making abilities after your ACL injury.